The proto-oncogene KRAS, coding a membrane-associated GTPase signaling protein that regulates proliferation, differentiation, and cell survival, is mutated in 30–50% of lung adenocarcinomas, the most common histological subtype of non–small cell lung cancer (NSCLC) [1–3]. This evidence concerns the gene KRAS and lung adenocarcinoma.